DCGO

DocGo Inc. (DCGO) | Rumor.io

DocGo

DCGO

Attention (50-day avg)0%

Attention rank (50-day avg)#2,230

Bullish sentiment (50-day avg)82%

Price to earnings ratio8.47

Market capitalization36.1M

Earnings per share-2.06

Dividend yield (TTM)—

Revenue (annual)322.2M

Net income (annual)-196.4M

Social

What share of all stock conversation is about DCGO?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% 0	0% +0

Sep 29

DCGO's management is under pressure to deliver results, with one post stating "it's time for you to do something for the shareholders who you've slaughtered."
The company's synergies with Hicuity, a tele-ICU services provider, are seen as a key growth area, but there are concerns about revenue growth and the potential for market saturation.
DCGO's stock price is volatile, with one post stating "perfect trash" and another calling for a "timeline for incoming NYC money" to boost the business.

Generated by AI

Sentiment

Of the messages about DCGO that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100% 0	100% +28.57	92.11% +13.53	91.83% +5.97
Bearish	0% 0	0% -28.57	7.89% -13.53	8.17% -5.97

Bullish· Sep 1

$DCGO is expected to take off, with the potential for significant price increases.
DocGo's acquisition of SteadyMD and Hicquity is believed to be undervalued by the market, with the company's other business lines worth $0.
A double bottom pattern has formed in $DCGO, indicating a potential reversal in the stock's price trend.

Bearish· Oct 21

$DCGO's price action is being manipulated, leading to unrealistic gains.
Despite a strong volume, the stock's performance is lackluster, failing to meet expectations.
Traders are dumping the stock, and those who remain are at risk of significant losses.

Generated by AI

Topics

Of the messages about DCGO that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	66.67%	50%	74.43%
Controversies	—	0%	25%	1.53%
Technical Analysis	—	33.33%	25%	9.54%
Analysts	—	0%	0%	6.11%
Earnings	—	0%	0%	8.02%
Macro	—	0%	0%	0.38%

Oct 21

DocGo Inc. (DCGO) has acquired SteadyMD, a nationwide virtual-care platform, expanding its reach to all 50 US states and adding 600+ clinicians.
The acquisition is expected to generate $25M in 2025 revenue and be EBITDA-positive by 2026, with no dilution to existing shareholders.
DocGo's core business, providing ambulatory services for ER and patient transfer, has seen improved margins and cash flow, supporting expansion into new areas.

Generated by AI

Community

Of the messages about DCGO, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	100%	64.29%	31.59%
Newcomers	0%	0%	35.71%	68.41%

Regulars· Sep 29

The CEO, Lee, has stated that the company aims to work in synergies to reduce SG&A costs and increase margins, and that the growth expectations are more on the part of DocGo to provide services riding on Hicuity's customer base than for Hicuity to grow.
The company has announced plans to exit the year on a profitable run rate, pay down debt with NYC collections, and service the debt that was assumed from Hicuity in the deal.
The CEO has also mentioned that the company will receive payments from NYC in Q4, and that there is a massive opportunity for DocGo to offer its services in the aging healthcare market, with synergies with Hicuity.

Newcomers· Sep 1

Newcomers are predicting a price increase for $DCGO, with some calling it the "next big mover".
Many users are sharing their predictions and excitement about the potential rise of $DCGO, with some already celebrating a "red to green" shift.
The .39 price level is being watched closely by some users, who are encouraging buyers to step in and potentially break through this level.

Generated by AI

News

DocGo at Morgan Stanley healthcare conference: margin push takes center stage

13d agoInvesting.com

DocGo Earnings Call: Growth Momentum Meets Margin Strain

Detailed price information for Docgo Inc. (DCGO-Q) from The Globe and Mail including charting and trades.

1mo agoThe Globe and Mail

Analysts Offer Insights on Healthcare Companies: NRX Pharmaceuticals (NRXP), DocGo (DCGO) and Ardelyx (ARDX)

Detailed price information for Ardelyx Inc (ARDX-Q) from The Globe and Mail including charting and trades.

1mo agoThe Globe and Mail

Analysts Offer Insights on Healthcare Companies: Invivyd (IVVD), Traws Pharma (TRAW) and DocGo (DCGO)

Detailed price information for Invivyd Inc (IVVD-Q) from The Globe and Mail including charting and trades.

1mo agoThe Globe and Mail

DocGo stock price target maintained at $2.50 by Stifel

1mo agoInvesting.com

Needham reiterates DocGo stock rating on Hicuity acquisition

1mo agoInvesting.com

Also Discussed

Investors talking about DCGO also mention

#	Name	Attention
1	BMTX - BM Technologies, Inc.	——
2	Better Therapeutics, Inc.BTTX	0%new
3	Valens Semiconductor Ltd.VLN	0%new
4	Clearfield, Inc.CLFD	0%0
5	Xponential Fitness Inc.XPOF	0%new
6	Heritage Global Inc.HGBL	0%0
7	Scienture Holdings, Inc.SCNX	0%0
8	PLANET LABS PBCPL	0.27%+0.25
9	Vintage Wine Estates, Inc.VWE	0%0
10	Super Group (SGHC) LimitedSGHC	0%0

DocGo Inc.

Healthcare
Medical Care Facilities

DocGo Inc. is a healthcare services company that provides mobile health and medical transportation solutions for patients, hospitals, health systems, insurers, employers, and public-sector organizations. DocGo Inc. combines proprietary technology with skilled clinicians to deliver care through mobile and virtual channels, including in-home and on-site urgent care, diagnostic testing, vaccinations, monitoring, care management, and remote patient support. Its transportation services include emergency response and non-emergency medical transport such as ambulance and wheelchair services. The company also supports event-based healthcare coverage and mobile clinical programs designed to extend care beyond traditional facilities. Headquartered in New York, DocGo Inc. plays a role in the shift toward more accessible, decentralized care delivery across the United States and the United Kingdom.

Website

Location

685 Third Avenue

New York, NY, 10017

United States

Social

What share of all stock conversation is about DCGO?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% 0	0% +0

Sep 29

DCGO's management is under pressure to deliver results, with one post stating "it's time for you to do something for the shareholders who you've slaughtered."
The company's synergies with Hicuity, a tele-ICU services provider, are seen as a key growth area, but there are concerns about revenue growth and the potential for market saturation.
DCGO's stock price is volatile, with one post stating "perfect trash" and another calling for a "timeline for incoming NYC money" to boost the business.

Generated by AI

Sentiment

Of the messages about DCGO that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100% 0	100% +28.57	92.11% +13.53	91.83% +5.97
Bearish	0% 0	0% -28.57	7.89% -13.53	8.17% -5.97

Bullish· Sep 1

$DCGO is expected to take off, with the potential for significant price increases.
DocGo's acquisition of SteadyMD and Hicquity is believed to be undervalued by the market, with the company's other business lines worth $0.
A double bottom pattern has formed in $DCGO, indicating a potential reversal in the stock's price trend.

Bearish· Oct 21

$DCGO's price action is being manipulated, leading to unrealistic gains.
Despite a strong volume, the stock's performance is lackluster, failing to meet expectations.
Traders are dumping the stock, and those who remain are at risk of significant losses.

Generated by AI

Topics

Of the messages about DCGO that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	66.67%	50%	74.43%
Controversies	—	0%	25%	1.53%
Technical Analysis	—	33.33%	25%	9.54%
Analysts	—	0%	0%	6.11%
Earnings	—	0%	0%	8.02%
Macro	—	0%	0%	0.38%

Oct 21

DocGo Inc. (DCGO) has acquired SteadyMD, a nationwide virtual-care platform, expanding its reach to all 50 US states and adding 600+ clinicians.
The acquisition is expected to generate $25M in 2025 revenue and be EBITDA-positive by 2026, with no dilution to existing shareholders.
DocGo's core business, providing ambulatory services for ER and patient transfer, has seen improved margins and cash flow, supporting expansion into new areas.

Generated by AI

Community

Of the messages about DCGO, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	100%	64.29%	31.59%
Newcomers	0%	0%	35.71%	68.41%

Regulars· Sep 29

The CEO, Lee, has stated that the company aims to work in synergies to reduce SG&A costs and increase margins, and that the growth expectations are more on the part of DocGo to provide services riding on Hicuity's customer base than for Hicuity to grow.
The company has announced plans to exit the year on a profitable run rate, pay down debt with NYC collections, and service the debt that was assumed from Hicuity in the deal.
The CEO has also mentioned that the company will receive payments from NYC in Q4, and that there is a massive opportunity for DocGo to offer its services in the aging healthcare market, with synergies with Hicuity.

Newcomers· Sep 1

Newcomers are predicting a price increase for $DCGO, with some calling it the "next big mover".
Many users are sharing their predictions and excitement about the potential rise of $DCGO, with some already celebrating a "red to green" shift.
The .39 price level is being watched closely by some users, who are encouraging buyers to step in and potentially break through this level.

Generated by AI

DocGo

Social

Sep 29

Bullish· Sep 1

Bearish· Oct 21

Oct 21

Regulars· Sep 29

Newcomers· Sep 1

DocGo at Morgan Stanley healthcare conference: margin push takes center stage

DocGo Earnings Call: Growth Momentum Meets Margin Strain

Analysts Offer Insights on Healthcare Companies: NRX Pharmaceuticals (NRXP), DocGo (DCGO) and Ardelyx (ARDX)

Analysts Offer Insights on Healthcare Companies: Invivyd (IVVD), Traws Pharma (TRAW) and DocGo (DCGO)

DocGo stock price target maintained at $2.50 by Stifel

Needham reiterates DocGo stock rating on Hicuity acquisition

Also Discussed

DocGo Inc.

Company Information

Location

DocGo at Morgan Stanley healthcare conference: margin push takes center stage

DocGo Earnings Call: Growth Momentum Meets Margin Strain

Analysts Offer Insights on Healthcare Companies: NRX Pharmaceuticals (NRXP), DocGo (DCGO) and Ardelyx (ARDX)

Analysts Offer Insights on Healthcare Companies: Invivyd (IVVD), Traws Pharma (TRAW) and DocGo (DCGO)

DocGo stock price target maintained at $2.50 by Stifel

Needham reiterates DocGo stock rating on Hicuity acquisition

Also Discussed

Social

Sep 29

Bullish· Sep 1

Bearish· Oct 21

Oct 21

Regulars· Sep 29

Newcomers· Sep 1